As he begins his transition to the presidency, Joe Biden is pivoting from a bitter campaign battle to another, more pressing fight: reining in the pandemic that has hit the world’s most powerful nation harder than any other. The U.S….
Read More
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly: study
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October…
Read More
Response to adjuvant bevacizumab among patients with resected melanoma may vary by age
Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic bevacizumab (Avastin) while older patients with resected melanoma did not, according to results published in Clinical Cancer Research, a journal of the American Association for…
Read More
Study shows similar antibody response to key SARS-CoV-2 ‘spike’ protein in COVID-19
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that antibody responses to SARS-CoV-2 are similar in COVID-19 patients with and without diabetes, and thus are unlikely to be responsible for the…
Read More
Researchers demonstrate how changing the stem cell response to inflammation may reverse periodontal disease
Periodontal disease, also known as gum disease, is a serious infection that affects nearly 50 percent of Americans aged 30 years and older. If left unchecked, periodontal disease can destroy the jawbone and lead to tooth loss. The disease is…
Read More
Mental health and brain research must be a higher priority in global COVID-19 response
A new paper, to be published today in The Lancet Psychiatry, highlights an urgent need to tackle the harmful impacts of the COVID-19 pandemic on mental health and potentially the brain and calls for research on these areas to be…
Read More
Countries groping for best coronavirus response: Expert
Sharon Lewin, director of The Peter Doherty Institute for Infection and Immunity in Melbourne and a top expert on infectious disease policy, spoke with AFP about the unfolding coronavirus pandemic. Countries that got caught off-guard or did not respond to…
Read More
Blood test can predict clinical response to immunotherapy in metastatic NSCLC
Non-small cell lung cancer (NSCLC) patients with higher measures of tumor mutations that show up in a blood test generally have a better clinical response to PD-1-based immunotherapy treatments than patients with a lower measure of mutations. A clinical trial…
Read More